This review considers current evidence supporting a mechanistic link between mCRP/CRP/IL-6 signaling and the amplification of stress and pain sensitivity, contributing to a broader understanding of how systemic inflammation may drive vulnerability to neurodegenerative disease. The gene discussed is CRP; the disease is neurodegenerative disease.